Vanja Sisirak

4.3k total citations
30 papers, 2.8k citations indexed

About

Vanja Sisirak is a scholar working on Immunology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Vanja Sisirak has authored 30 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 5 papers in Pathology and Forensic Medicine and 5 papers in Rheumatology. Recurrent topics in Vanja Sisirak's work include Immunotherapy and Immune Responses (18 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (13 papers). Vanja Sisirak is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (13 papers). Vanja Sisirak collaborates with scholars based in France, United States and Germany. Vanja Sisirak's co-authors include Boris Reizis, Dipyaman Ganguly, Kanako L. Lewis, Hiyaa S. Ghosh, Stefan Haak, Anna Bunin, Christophe Caux, Nathalie Bendriss‐Vermare, Jean‐Yves Blay and Christine Ménétrier‐Caux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Vanja Sisirak

30 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanja Sisirak France 21 2.2k 704 565 263 203 30 2.8k
Magdalena Huber Germany 27 2.3k 1.1× 904 1.3× 570 1.0× 135 0.5× 315 1.6× 62 3.3k
Kotaro Suzuki Japan 30 1.7k 0.8× 510 0.7× 638 1.1× 375 1.4× 249 1.2× 77 2.9k
Toshiyuki Hori Japan 31 2.4k 1.1× 974 1.4× 628 1.1× 151 0.6× 167 0.8× 75 3.8k
John Simard United States 17 1.9k 0.9× 548 0.8× 684 1.2× 129 0.5× 141 0.7× 24 3.0k
Youjin Lee United States 16 3.0k 1.4× 1.3k 1.8× 709 1.3× 170 0.6× 189 0.9× 17 3.9k
Ivana M. Djuretic United States 16 1.7k 0.8× 573 0.8× 500 0.9× 91 0.3× 120 0.6× 27 2.3k
Cory L. Ahonen United States 16 2.1k 1.0× 1.0k 1.5× 542 1.0× 112 0.4× 240 1.2× 19 3.0k
Marc Ehlers Germany 23 1.3k 0.6× 421 0.6× 551 1.0× 205 0.8× 135 0.7× 49 2.0k
Evemie Schutyser Belgium 22 1.6k 0.7× 1.4k 2.0× 661 1.2× 176 0.7× 217 1.1× 30 2.8k
Geoffrey L. Stephens United States 20 2.7k 1.2× 596 0.8× 451 0.8× 315 1.2× 115 0.6× 23 3.7k

Countries citing papers authored by Vanja Sisirak

Since Specialization
Citations

This map shows the geographic impact of Vanja Sisirak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanja Sisirak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanja Sisirak more than expected).

Fields of papers citing papers by Vanja Sisirak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanja Sisirak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanja Sisirak. The network helps show where Vanja Sisirak may publish in the future.

Co-authorship network of co-authors of Vanja Sisirak

This figure shows the co-authorship network connecting the top 25 collaborators of Vanja Sisirak. A scholar is included among the top collaborators of Vanja Sisirak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanja Sisirak. Vanja Sisirak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubois, Maxime, Émeline Levionnois, Paôline Laurent, et al.. (2024). The deficiency of DNASE1L3 does not affect systemic sclerosis pathogenesis in two inducible murine models of the disease. European Journal of Immunology. 54(6). e2350903–e2350903. 1 indexed citations
2.
Duluc, Dorothée & Vanja Sisirak. (2023). Origin, Phenotype, and Function of Mouse Dendritic Cell Subsets. Methods in molecular biology. 2618. 3–16. 1 indexed citations
3.
Loizon, Séverine, et al.. (2023). Enrichment of Large Numbers of Splenic Mouse Dendritic Cells After Injection of Flt3L-Producing Tumor Cells. Methods in molecular biology. 2618. 173–186. 1 indexed citations
4.
Serpas, Lee, et al.. (2021). The Role of Nucleases and Nucleic Acid Editing Enzymes in the Regulation of Self-Nucleic Acid Sensing. Frontiers in Immunology. 12. 629922–629922. 41 indexed citations
5.
Ferrière, Amandine, et al.. (2021). Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome. Frontiers in Immunology. 11. 624256–624256. 15 indexed citations
6.
Soni, Chetna, Oriana A. Perez, William N. Voss, et al.. (2020). Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA. Immunity. 52(6). 1022–1038.e7. 125 indexed citations
7.
Levionnois, Émeline, Paôline Laurent, Estibaliz Lazaro, et al.. (2020). Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis. Frontiers in Immunology. 11. 532177–532177. 17 indexed citations
8.
Sawai, Catherine M., Lee Serpas, Antonio Galvao Neto, et al.. (2018). Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease. Frontiers in Immunology. 9. 2475–2475. 16 indexed citations
9.
Scherlinger, Marc, Vivien Guillotin, Marie‐Elise Truchetet, et al.. (2018). Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets. Autoimmunity Reviews. 17(6). 625–635. 64 indexed citations
10.
Laurent, Paôline, Vanja Sisirak, Estibaliz Lazaro, et al.. (2018). Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances. Frontiers in Immunology. 9. 1702–1702. 45 indexed citations
11.
Scherlinger, Marc, Vanja Sisirak, Christophe Richez, et al.. (2017). New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus. Current Rheumatology Reports. 19(8). 48–48. 32 indexed citations
12.
Bunin, Anna, Vanja Sisirak, Hiyaa S. Ghosh, et al.. (2015). Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells. Immunity. 43(2). 277–288. 43 indexed citations
13.
Dezutter‐Dambuyant, Colette, Isabelle Durand, Laurent Alberti, et al.. (2015). A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage. OncoImmunology. 5(3). e1091146–e1091146. 74 indexed citations
14.
Mercier, Isabelle Le, Dominique Poujol, Amélien Sanlaville, et al.. (2013). Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment. Cancer Research. 73(15). 4629–4640. 156 indexed citations
15.
Faget, Julien, Vanja Sisirak, Jean‐Yves Blay, et al.. (2013). ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+T cells by plasmacytoid dendritic cells. OncoImmunology. 2(3). e23185–e23185. 65 indexed citations
16.
Sisirak, Vanja, Julien Faget, Michael Gobert, et al.. (2012). Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression. Cancer Research. 72(20). 5188–5197. 269 indexed citations
17.
Sisirak, Vanja, Julien Faget, Nelly Vey, et al.. (2012). Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+regulatory T cells and are associated with poor prognosis in breast cancer patients. OncoImmunology. 2(1). e22338–e22338. 47 indexed citations
18.
Labidi‐Galy, Sana Intidhar, Vanja Sisirak, Pierre Méeus, et al.. (2011). Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer. Cancer Research. 71(16). 5423–5434. 187 indexed citations
19.
Duthey, Béatrice, Vanja Sisirak, Danièle Salaün, et al.. (2011). Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene. 31(30). 3516–3524. 34 indexed citations
20.
Flacher, Vincent, Marielle Bouschbacher, Estelle Verronèse, et al.. (2006). Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria. The Journal of Immunology. 177(11). 7959–7967. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Huber Breakdown of academic impact, for papers by Kotaro Suzuki Breakdown of academic impact, for papers by Toshiyuki Hori Breakdown of academic impact, for papers by John Simard Breakdown of academic impact, for papers by Youjin Lee Breakdown of academic impact, for papers by Ivana M. Djuretic Breakdown of academic impact, for papers by Cory L. Ahonen Breakdown of academic impact, for papers by Marc Ehlers Breakdown of academic impact, for papers by Evemie Schutyser Breakdown of academic impact, for papers by Geoffrey L. Stephens
Rankless by CCL
2026